Next Article in Journal
Could Pontimonas Harbour Halophilic Members Able to Withstand Very Broad Salinity Variations?
Next Article in Special Issue
Assessing the Synergistic Activity of Clarithromycin and Therapeutic Oils Encapsulated in Sodium Alginate Based Floating Microbeads
Previous Article in Journal
Anti-Melanogenic and Antioxidant Effects of Cell-Free Supernatant from Lactobacillus gasseri BNR17
Previous Article in Special Issue
Trichogenic Silver-Based Nanoparticles for Suppression of Fungi Involved in Damping-Off of Cotton Seedlings
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Microorganisms
Volume 10
Issue 4
10.3390/microorganisms10040789
microorganisms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Biomimetic Synthesis of Silver Nanoparticles Using Ethyl Acetate Extract of Urtica diocia Leaves; Characterizations and Emerging Antimicrobial Activity

by
Mohammed Binsalah
1,
Sandhanasamy Devanesan
2,*,
Mohamad S. AlSalhi
2,*,
Abdullrahman Nooh
3,
Osama Alghamdi
1 and
Nasser Nooh
1
1
Department of Oral and Maxillofacial Surgery, College of Dentistry, King Saud University, Riyadh 11545, Saudi Arabia
2
Research Chair in Laser Diagnosis of Cancers, Department of Physics and Astronomy, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
3
Department of Internal Medicine, Prince Mohammed Bin Abdulaziz Hospital, Riyadh 7333, Saudi Arabia
*
Authors to whom correspondence should be addressed.
Microorganisms 2022, 10(4), 789; https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms10040789
Submission received: 21 February 2022 / Revised: 31 March 2022 / Accepted: 5 April 2022 / Published: 8 April 2022
(This article belongs to the Special Issue Microbial Nanotechnology)
Browse Figures
Versions Notes

Abstract

:
The current work reports the biosynthesis of silver nanoparticles (AgNPs) using the antimicrobial activities of ethyl acetate extract of Urtica diocia (UD) leaves as a reducing and capping agent. The synthesized UD-AgNPs were characterized using UV–visible spectroscopy, scanning electron microscopy (SEM), transmission electron microscopy (TEM), energy-dispersive X-ray analysis (EDAX), Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), and dynamic light scattering (DLS). The UD-AgNPs were evaluated against Gram-positive and Gram-negative bacteria, and their size, shape, and distribution were recorded. The average size of an NP was 19.401 nm. The zone of inhibition (ZOI) for 75 µL of UD-AgNPs against Pseudomonas aeruginosa (P. aeruginosa) was 21 ± 0.4 mm more than that of the control drug Ciprofloxacin (16 ± 10 mm). The minimum inhibitory concentration (MIC) was the lowest against Escherichia coli (E. coli) (36 ± 3 µg/mL) and Staphylococcus epidermidis (S. epidermidis) (38 ± 3 µg/mL). Moreover, the minimum bactericidal concentration (MBC) was the lowest against E. coli (75 ± 00 µg/mL) and Enterococcus faecalis (E. faecalis (83 ± 16 µg/mL). Thus, the UD-AgNPs synthesized using the ethyl acetate extract of UD can be used as a new antimicrobial drug.

1. Introduction

The benefits of medicinal plants have been intensively investigated for many centuries, as their natural components contain biologically active organic products, have few adverse effects, and are relatively low cost. It is estimated that plant products have provided the models for 50% of Western drugs [1]. Urtica diocia L. (UD), also known as stinging nettle, is an important medicinal plant that has been used since ancient times, and recent studies have reported that its leaves are a good food additive rich in medicinal value [2,3]. In addition, the crude extract of nettle plant leaves has been used to reduce inflammation [4] and maintain blood sugar levels in static conditions [5]. Multiple studies have also reported that the medicinal properties of UD include bleeding control and wound and burn healing. It also acts as a diuretic [6,7,8]. Moreover, crude UD extract has been reported as an antimicrobial agent against Gram-positive and Gram-negative microorganisms [9].
Antibiotic overdose as a result of an infectious disease treatment can lead to the emergence of multidrug-resistant (MDR) bacteria [10]. It has been documented that the Gram-positive bacterium S. epidermidis is MDR, which poses a healthcare management challenge [11]. This issue became a significant area of research into the formation of alternative neutral antibacterial agents with unique characteristics [12]. Advances in nanotechnology have allowed for the production of nanoparticles that show low toxicity against human cells and are reported to have promising bactericidal activity [13]. Phyto-nanotechnology, or plant-based nanomedicine, is used extensively in numerous fields in the form of nanoparticles (NPs) that enhance the activity of materials [14]. Recently, researchers have focused their attention on plant product-inspired metal NPs and their biomedical importance [15].
Among the different metal-based NPs, biosynthesized silver NPs (AgNPs) are well documented [16,17], biocompatible, and have few adverse effects [18]. Even a minimal amount of AgNPs has been shown to demonstrate antimicrobial [19], anticancer [20], antidiabetic [21], antiviral [22], and antioxidant properties [23]. Importantly, the synthesis of plant extract-based NPs is affordable, eco-friendly, and effective for formulating antimicrobial drugs [24]. The phytochemical screening of AgNPs containing Phoenix dactylifera L. leaf extract indicated polyphenols, flavonoids, and condensed tannins. These compounds play a vital role as a reducing and capping agent to inhibit particle growth and aggregation [25]. In addition, AgNPs from aqueous oregano plant leaf extract have been reported as non-infectious for sterile antimicrobial contact lenses [26].
The AgNPs synthesized with UD extract have been shown to protect the liver of cirrhotic rats [27]; similarly, AgNPs synthesized with Urtica urens are an effective nematicide against the root-knot nematode Meloidogyne [28]. A few studies have reported the antioxidant and antimicrobial effects of UD-AgNP aqueous extract [29,30] and methanol extract [31], indicating various effects such as the amount of AgNO3; however, reports on the size of the AgNPs and the concentration of UD-AgNPs in biological activities were absent. The current study aimed to conduct a green synthesis of AgNPs with ethyl acetate leaf extract of UD. The synthesized UD-AgNPs were characterized using UV–Vis, XRD, FTIR, SEM, TEM, EDX, and DLS analysis, and they were investigated for antimicrobial activity against Gram-positive and Gram-negative bacterial strains.

2. Materials and Methods

2.1. Collection and Preparation of Plant leaves

Fresh UD leaves, collected from the Riyadh region of Saudi Arabia, were rinsed with tap water and then with Milli Q water (ultrapure and deionized water purified by a Milli-Q water system, Merk, Darmstadt, Germany) to remove surface contaminants and other dust particles. The cleaned leaves were dried entirely at room temperature, after which 100 g of the dried leaves were milled into a fine powder [29].

2.2. UD Leaf Extraction

Ethyl acetate was used as the extraction solvent since it has a medium polarity with minimal cell toxicity. In brief, 10 mL of fine blended powder of UD leaves was poured into a Soxhlet extractor chamber. Then, 250 mL of ethyl acetate was placed in a round-bottomed flask and boiled at 77.1 °C [32]. This process was carried out in 24 h, and the ethyl acetate extracted compounds were retained.

2.3. Preparation of UD-AgNPs

Briefly, 1 mM of silver nitrate (AgNO3) dissolved in 250 mL of Milli Q water was added to 10 mL of ethyl acetate UD extract. The mixture was stirred continuously in a shaking incubator for 24 h and then monitored for interaction between the AgNO3 and the UD extract. The reaction (color changes) of the mixture started from 8 h onwards and turned completely dark brown within 24 h. The colored solution was placed in a rotary evaporator (Rotavapor R-215, Marshall Scientific, USA) at 45° C at 75 rpm to remove the solvent. The solution was centrifuged at 15,000 rpm for 15 min three times. The supernatant was discarded, and the NPs sedimented at the bottom of the centrifuge tube. The NP sediment tube was allowed to dry in an incubator at 40 °C for 2 h before collection [33,34]. The collected semisolid UD-AgNPs were kept at 4 °C for characterization and biological study [35].

2.4. Characterization

The absorption spectrum of the reaction mixture (AgNO3 + plant extract) after the stabilization of color was characterized by a UV–Vis spectrophotometer (LS 55; Perkin-Elmer, Rodgau, Germany). The size and shape of the UD-AgNPs were recorded using SEM (JEOL, Tokyo, Japan), TEM (JEOL), EDAX, XRD, and FTIR, according to the literature [14,15]. The size of the UD-AgNPs was determined by a Zetasizer DLS instrument (Malvern Instruments, Malvern, U.K).

2.5. Antimicrobial Evaluation

2.5.1. Inhibition Study

The antibacterial activity of UD-AgNPs was evaluated against the following Gram-positive pathogens: S. aureus (ATCC®29213), E. faecalis (ATCC®29212), and S. epidermidis (ATCC®12228), as well as the following Gram-negative pathogens: Klebsiella pneumoniae (K. pneumoniae) (ATCC®700603), P. aeruginosa (ATCC®27853), and E. coli (ATCC®25922). In addition, their antimicrobial susceptibility was determined using Mueller–Hinton agar (MHA) plates [11,12]. Briefly, 19 g of MHA powder was mixed with 500 mL of distilled water and then sterilized in an autoclave at 121 °C for 15 min. Next, approximately 25 mL of the medium was poured into each plate, which had been inoculated with an adjusted bacterial concentration (108 CFU/mL, 0.5 McFarland’s standard). Then, 40 mg of UD-AgNPs was dissolved in 20 mL of dimethyl sulfoxide (DMSO). Three different concentrations of UD-AgNPs in DMSO (25, 50, and 75 µL) were added to the plates. Ciprofloxacin (10 µL) was used as a positive control drug. The negative controls were DMSO, ethyl acetate UD extract, and AgNO3 (75 µL). The plates were incubated at 37 °C for 24 h. After incubation, the ZOI around the well, indicating the antimicrobial activity of the UD-AgNPs, was measured in mm [36].

2.5.2. MIC

The MIC was determined by a resazurin-based assay using UD-AgNP concentrations ranging from 15 to 50 µg/mL with an adjusted bacterial concentration (108 CFU/mL, 0.5 McFarland’s standard). Three 96-well plates were used for the MIC evaluation. In the first plate, the first six columns were filled with 190 µL of Mueller–Hinton Broth (MHB) and 10 µL of each type of pathogen as a positive control. In comparison, the other six columns of the first plate and the second plate were treated with serial dilutions of UD-AgNPs, with concentrations ranging from 15 to 50 µg/mL (15, 20, 25, 30, 35, 40, 45, and 50 µg/mL) and 10 µL of each type of pathogen. In the third plate, three columns were filled with 150 µL of MHB and used as a negative control. After incubation for 24 h, 15 µL of 0.02% resazurin solution (5 mg in 25 mL of distilled water) was added to each well of the microtiter plates, and the plates were further incubated at 37 °C for 4 h. Color changes were recorded, and the MIC values were determined. The MIC was considered the lowest concentration of the UD-AgNPs that inhibited bacterial growth [37].

2.5.3. MBC

The MBC was determined according to the protocol of the Clinical and Laboratory Standards Institute, and MHA plates were used for the MBC experiments. Briefly, 10 µL of pathogen was inoculated onto each plate, and then different amounts of UD-AgNPs (25, 50, 75, 100, 150, 200, 250, and 500 µL) of a mixture of 40 mg of UD-AgNPs dissolved in 20 mL of DMSO were applied to the agar plates. The plates were incubated at 37 °C for 24 h. The plates started with no visible bacterial growth in specific concentrations considered as MBC. The MBC value of the UD-AgNPs for each tested microorganism was determined [38].

2.6. Statistical Analysis

The experimental data were analyzed using one-way ANOVA. The data were represented as the mean ± standard deviation (SD). The experiments were performed with a level of significance of p ≤ 0.05.

3. Results

3.1. Characterizations

3.1.1. Visual Observation

The combination of the ethyl acetate extract of UD leaves and the AgNO3 solution produced UD-AgNPs after 8 h. Initially, the AgNO3 solution was colorless, and the mixture of AgNO3 and the plant extract was yellow, as shown in Figure 1a,b. After stirring for 8 h, the mixture of the ethyl acetate extract of UD leaves and AgNO3 solution turned dark brown, indicating the formation of UD-AgNPs (Figure 1c). The change in color was due to the interaction between the UD leaf extract and the formation of capping and reducing agents (Ag+ to Ag).

3.1.2. UV–vis Spectral Study

The UV–vis spectral images at different time points (8, 16, and 24 h) showed the progression of NP formation. An absorbance peak was noted at 420 nm (Figure 2). Surface plasmon resonance experiments indicated that the solution of UD-AgNPs was stable for 24 h.

3.1.3. FTIR Spectroscopy

The FTIR spectrum indicated the ethyl acetate leaf extract alone (Figure 3a) and the synthesized UD-AgNPs (Figure 3b). The FTIR absorption spectra of acetate leaf extract alone peaked at 3433, 2925, 1730, 1624, 1166, and 611 cm−1. In contrast, the synthesized UD-AgNPs absorption peaks were shifted slightly at 3430, 2924, 1626, 1018, and 564 cm−1. The strong absorption peaks at 3430 cm−1 corresponded to the N–H stretch (primary amine). In addition, a long, narrow band was seen at 2924 cm−1, indicating the presence of C–H stretching (alkane). Strong bands were also noted at 1626 cm−1, representing C=C stretching (alkene). Moreover, bands were formed at 1018 cm−1, corresponding to C–N stretching (amines). Another peak at 564 cm−1 belonged to the C–I or C–Br group of the compounds. The similar spectral features for acetate leaf extract alone and the synthesizeVirulence determinants of uropathogenic Escherichia coli in fecal strains from intestinal infections and healthy individuals. UD-AgNPs may have indicated the presence of the identified phytochemicals in the synthesized UD-AgNPs.

3.1.4. XRD Pattern

The UD-AgNPs were studied using XRD, and the results are shown in Figure 4. The XRD pattern exhibited peaks at the two theta values of 38.12, 46.26, 57.40, and 76.98°, corresponding to the hkl plane Bragg reflections 111, 200, 220, and 311, respectively. The XRD spectrum confirmed that the synthesized UD-AgNPs had a face-centered cubic structure. The unassigned peak (*), observed at 55°, could have been caused by bioorganic compounds in the synthesized NPs.

3.1.5. DLS Analysis

The DLS Zetasizer was used to determine the size distribution and the surface intensity of the synthesized UD-AgNPs (Figure 5a–b). The size distribution was measured based on the intensity fluctuation yields of the rate of Brownian motion (Figure 5a). The DLS result exhibited the average peak intensity values in the hydrodynamic diameter distribution with relatively homogenous distribution in the polydispersity index (PDI: 0.47 ± 0.31).
The zeta potential result indicated that the distribution of NPs was equal, without any aggregation of UD-AgNPs (Figure 5b). The negative value (−15.5 ± 0.6 mV) of the zeta potential confirmed the size distribution and low aggregation of the synthesized UD-AgNPs, which was important for understanding their stability.

3.1.6. EDAX Analysis

As depicted in Figure 6, the EDAX for the elemental distribution in the synthesized UD-AgNPs shows that the elemental composition of Ag–L (48.53% mass) was higher than that of the other components: C–K (24.12% mass), O–K (17.80% mass), and Cl–K (9.55% mass). These results demonstrated that the AgNPs synthesized with UD-based NPs were pure.

3.1.7. SEM and TEM Images

The SEM images of the UD-AgNPs shown in Figure 7a,b reveal that the UD-AgNPs were spherical and did not aggregate. The images confirmed the formation of AgNPs. The TEM images of the UD-AgNPs depicted in Figure 7c,d showed that the UD-AgNPs had a spherical shape ranging from 8.2 to 56.1 nm, with an average size of 19.4 nm.

3.2. Antimicrobial Susceptibility

The antimicrobial susceptibility of the UD-AgNPs against Gram-positive and Gram-negative bacteria was tested at 25, 50, and 75 µL. Ciprofloxacin (10 µL) was used as a positive control, and the negative control test was performed using DMSO, ethyl acetate UD leaf extract, and AgNO3 (75 µL). No record was found related to ZOI in the tested microorganisms (Figure 8a). The ZOI results of Gram-positive bacteria S. aureus, E. faecalis, and S. epidermidis, as well as those of the Gram-negative bacteria E. coli, K. pneumoniae, and P. aeruginosa are given in Figure 8b. The ZOI values are shown in Table 1. Compared to the other Gram-positive bacteria, the maximum ZOI was recorded for S. epidermidis (19 ± 1 mm). Among the Gram-negative bacteria, P. aeruginosa exhibited the highest ZOI value (21.6 ± 0.4 mm) (Table 1).

3.2.1. MIC Analysis

The MIC values of the UD-AgNPs against the Gram-positive bacteria S. aureus, E. faecalis, and S. epidermidis, as well as the Gram-negative bacteria E. coli, K. pneumoniae, and P. aeruginosa, were determined by assaying various concentrations of the UD-AgNPs (15, 20, 25, 30, 35, 40, 45, and 50 µg/mL). Three 96-well plates were used to assay the six microorganisms with the positive control (10 µL of each type of pathogen) and treatment (UD-AgNPs) incubated for 24 h at 37 °C. Resazurin dye (negative control) was used as a precursor to discriminate the actual MIC value of each tested organism. In this assay, the MIC values for each organism were based on color changes (Figure 9). The MIC values of the synthesized UD-AgNPs against the pathogens tested are shown in Table 2

3.2.2. MBC Analysis

The MBC values for both Gram-positive bacteria and Gram-negative bacteria are shown in Table 2. The results indicated that the UD-AgNPs indeed inhibited the growth of the tested pathogens.

4. Discussion

The current research focused on synthesizing AgNPs by using the medicinal plant UD, the leaf extract of which acted as a capping and reducing agent (AgNO3 into AgNPs) and presented numerous phytochemical compounds [25,26]. The formation of AgNPs was confirmed by changes in the color of the mixture [39] and the UV–vis spectral peak at 420–460 nm [40].
The FTIR spectrum showed strong absorption peaks corresponding to N–H and C–N; these amino groups played a role in the conversion process of Ag+ to Ag. The presence of C=C and C–H bonds revealed that the alkenyl groups were involved in the strengthening of AgNPs. The alkenyl group strengthened the AgNPs as a capping agent, which could selectively bind to different types of small plane surfaces to change their specific surface-free energies. The capping agents were involved in numerous important functions, such as preventing the agglomeration of nanoparticles and reducing toxicity. Moreover, alkenyl group molecules enhanced AgNPs in bacterial activities [41,42]. Another peak at 564 cm−1 indicated the presence of a C–Br group, the secondary structure of proteins that interacted with the NPs [29,43]. The reported wave numbers indicating signal stretching and vibrational bending of the peaks may have been derived from phytoconstituents such as flavonoids, terpenoids, alkaloids, and soluble proteins present in plant extracts. These compounds may have been responsible for chelating and capping in the bioreduction process [44,45]. The peaks indexed to the 111, 200, and 220 planes corresponded to the cubic structure of silver, and the Debye–Scherrer equation confirmed the small and crystalline NPs [46]. Because the synthesized NPs were small, their diffusion was very fast, as reported previously [47]. According to the DLS (PDI: 0.47 ± 031) and ZP results (−15.5 ± 0.6 mV), the size and surface charge of the NPs confirmed their therapeutic potential. These two traits influenced their kinetics and interaction with cellular and biological membranes, resulting in their efficacy [45].
Synthesized UD-AgNPs showed Ag–L (48.53% mass) was more abundant than other components such as C–K, O–K, and Cl–K by EDAX, as previously reported [48]. The presence of a trace amount of oxygen (17.80% mass) in the UD-AgNPs confirmed the roles played by the UD phytochemicals in the reduction in metal ions, capping agents, and NP stability. Based on these characterizations, it was clear that the synthesized UD-AgNPs were small, spherical, and not agglomerated. Size-related properties influenced the NP mode of action [49,50,51].
In the present study, the antimicrobial potency of the synthesized UD-AgNPs was studied against both Gram-positive and Gram-negative pathogens. Of the Gram-positive bacteria tested, S. epidermidis showed the greatest ZOI, indicating its high susceptibility to the AgNPs. The earlier study showed that the ZOI was greater for S. epidermidis, which was more sensitive to AgNPs [52]. In the case of the other pathogens (S. aureus and E. faecalis), they had a decreased uptake of UD-AgNPs, increased efflux pump activity, and increased drug-degrading enzymatic activity, which may be the reasons for their lower susceptibility to the UD-AgNPs.
Among the three Gram-negative pathogens tested, P. aeruginosa exhibited the largest ZOI, followed by E. coli and K. pneumoniae, indicating sensitivity to the UD-AgNPs. The internalization of the AgNPs in P. aeruginosa was greater than that of the other pathogens. Previous researchers have reported that P. aeruginosa is highly drug-resistant, which limits the use of many antibiotics. However, it is very interesting to note that this pathogen is highly sensitive to UD-AgNPs, as reported for a few other biosynthesized AgNPs [53,54]. The Gram-negative bacteria E. coli and K. pneumoniae have been found to be resistant to many drugs, but they were sensitive to the synthesized AgNPs. It has been reported that AgNPs induce a triclosan-like bactericidal mechanism to inhibit type II fatty-acid biosynthesis and generates oxidative stress in K. pneumoniae, which has shown antibacterial activity in multidrug-resistant K. pneumoniae [37]. Like K. pneumoniae with extended-spectrum beta-lactamase, E. coli is very sensitive to NPs, and the NPs inhibit the bacterium by making the cell shrink and impairing its membrane integrity [55]. In the present study, sensitivity studies showed that the Gram-negative bacteria were more susceptible to the action of AgNPs. It has been reported that the difference in cell wall components facilitates the entry of released ions from AgNPs more into the cells of Gram-negative than Gram-positive bacteria [56].
The MIC and MBC values reflected the susceptibility of the microbes to UD-AgNPs. The high MIC values against E. coli and S. epidermidis and MBC against E. coli and E. faecalis were due to the action of lipopolysaccharides against the trapped AgNPs, as reported previously [57]. This finding reflected the strong toxicity of UD-AgNPs against the microorganism [58]. Therefore, AgNPs can be used as nanobactericides and drug carriers, as reported [57]. Hence, the outcome of this study confirmed that the ethyl acetate-mediated synthesized UD-AgNPs acted as nanobactericides, meaning that they can penetrate bacterial envelopes to damage the cell membrane structure causing oxidative stress [59,60,61].

5. Conclusions

UD is a medicinal plant, and its leaves possess numerous medicinal properties, including controlling cardiovascular disorders and glucose homeostasis. Using the ethyl acetate extracts of UD leaves, AgNPs were synthesized in this study. The characterization of the synthesized NPs showed that the particles were spherical and small, and since small NPs have favorable therapeutic actions, the currently synthesized NPs have promising prospects for development as drugs. This characterization study further confirmed the presence of bioactive compounds in the leaves and that they became incorporated into the AgNPs. Such morphometric changes and functional adaptations promote the attachment of the AgNPs to the cell wall of the pathogen, which then internalizes the NPs, which in turn alter the internal environment of the bacterial cell and induce oxidative stress, causing changes in the DNA and the cellular enzymes that lead to bacterial cell death or functional inhibition. The ZOI, MIC, and MBC results showed that the synthesized NPs had bactericidal action against both Gram-positive and Gram-negative bacteria. Thus, future research should focus on the activity of the newly synthesized UD-AgNPs towards multidrug resistance and extended-spectrum beta-lactamase-containing and methicillin-resistant bacteria.

Author Contributions

S.D., M.S.A. and M.B., conceptualization, methodology; M.B. and S.D., experiments and data curations, original manuscript draft preparation; N.N., A.N. and O.A., review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The authors are grateful to the Deanship of Scientific Research, King Saud University, for funding through the Vice Deanship of Scientific Research Chairs.

Conflicts of Interest

The authors declare that no conflict of interest.

References

  1. Dar, S.A.; Ganai, F.A.; Yousuf, A.R.; Balkhi, M.-u.-H.; Bhat, T.M.; Sharma, P. Pharmacological and toxicological evaluation of Urtica dioica. Pharm. Biol. 2013, 51, 170–180. [Google Scholar] [CrossRef] [PubMed]
  2. Shonte, T.T.; Duodu, K.G.; de Kock, H.L. Effect of drying methods on chemical composition and antioxidant activity of underutilized stinging nettle leaves. Heliyon 2020, 6, e03938. [Google Scholar] [CrossRef] [PubMed]
  3. Nallan Chakravartula, S.S.; Moscetti, R.; Farinon, B.; Vinciguerra, V.; Merendino, N.; Bedini, G.; Neri, L.; Pittia, P.; Massantini, R. Stinging Nettles as Potential Food Additive: Effect of Drying Processes on Quality Characteristics of Leaf Powders. Foods 2021, 10, 1152. [Google Scholar] [CrossRef] [PubMed]
  4. Grauso, L.; de Falco, B.; Lanzotti, V.; Motti, R. Stinging nettle, Urtica dioica L.: Botanical, phytochemical and pharmacological overview. Phytochem. Rev. 2020, 19, 1341–1377. [Google Scholar] [CrossRef]
  5. Ziaei, R.; Foshati, S.; Hadi, A.; Kermani, M.A.H.; Ghavami, A.; Clark, C.C.; Tarrahi, M.J. The effect of nettle (Urtica dioica) supplementation on the glycemic control of patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Phytother. Res. 2020, 34, 282–294. [Google Scholar] [CrossRef]
  6. Singh, R.; Dar, S.; Sharma, P. Antibacterial activity and toxicological evaluation of semi purified hexane extract of Urtica dioica leaves. Res. J. Med. Plants 2012, 6, 123–135. [Google Scholar]
  7. Zehraw, H.M.; Taleb, Z.M.M.; Mukhlif, B.; Al-Jabbar, S.A. Extraction and evaluation the activity of Urtica dioica as bleeding stop material. Iraqi J. Biotechnol. 2019, 18, 77–87. [Google Scholar]
  8. Zouari Bouassida, K.; Bardaa, S.; Khimiri, M.; Rebaii, T.; Tounsi, S.; Jlaiel, L.; Trigui, M. Exploring the Urtica dioica leaves hemostatic and wound-healing potential. BioMed Res. Int. 2017, 2017, 1047523. [Google Scholar] [CrossRef] [Green Version]
  9. Modarresi-Chahardehi, A.; Ibrahim, D.; Fariza-Sulaiman, S.; Mousavi, L. Screening antimicrobial activity of various extracts of Urtica dioica. Rev. Biol. Trop. 2012, 60, 1567–1576. [Google Scholar] [CrossRef] [Green Version]
  10. Holmes, A.; Moore, L.; Sundsfjord, A.; Steinba, M.; Regmi, S.; Karey, A.; Guerin, P.J.; Piddoc, L.J.V. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 2016, 387, 176–187. [Google Scholar] [CrossRef]
  11. Chabi, R.; Momtaz, H. Virulence factors and antibiotic resistance properties of the Staphylococcus epidermidis strains isolated from hospital infections in Ahvaz, Iran. Trop. Med. Health 2019, 47, 1–9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Jain, D.; Daima, H.K.; Kachhwaha, S.; Kothari, S. Synthesis of plant-mediated silver nanoparticles using papaya fruit extract and evaluation of their anti-microbial activities. Dig. J. Nanomater. Biostruct. 2009, 4, 557–563. [Google Scholar]
  13. Abdel-Raouf, N.; Al-Enazi, N.M.; Ibraheem, I.B. Green biosynthesis of gold nanoparticles using Galaxaura elongata and characterization of their antibacterial activity. Arab. J. Chem. 2017, 10, S3029–S3039. [Google Scholar] [CrossRef] [Green Version]
  14. Dikshit, P.K.; Kumar, J.; Das, A.K.; Sadhu, S.; Sharma, S.; Singh, S.; Gupta, P.K.; Kim, B.S. Green Synthesis of Metallic Nanoparticles: Applications and Limitations. Catalysts 2021, 11, 902. [Google Scholar] [CrossRef]
  15. Devanesan, S.; AlSalhi, M.S. Green Synthesis of Silver Nanoparticles Using the Flower Extract of Abelmoschus esculentus for Cytotoxicity and Antimicrobial Studies. Int. J. Nanomed. 2021, 16, 3343. [Google Scholar] [CrossRef]
  16. AlSalhi, M.S.; Devanesan, S.; Alfuraydi, A.A.; Vishnubalaji, R.; Munusamy, M.A.; Murugan, K.; Nicoletti, M.; Benelli, G. Green synthesis of silver nanoparticles using Pimpinella anisum seeds: Antimicrobial activity and cytotoxicity on human neonatal skin stromal cells and colon cancer cells. Int. J. Nanomed. 2016, 11, 4439. [Google Scholar] [CrossRef] [Green Version]
  17. Devanesan, S.; Ponmurugan, K.; AlSalhi, M.S.; Al-Dhabi, N.A. Cytotoxic and antimicrobial efficacy of silver nanoparticles synthesized using a traditional phytoproduct, asafoetida gum. Int. J. Nanomed. 2020, 15, 4351. [Google Scholar] [CrossRef]
  18. Dakal, T.C.; Kumar, A.; Majumdar, R.S.; Yadav, V. Mechanistic basis of antimicrobial actions of silver nanoparticles. Front. Microbiol. 2016, 7, 1831. [Google Scholar] [CrossRef] [Green Version]
  19. Gurunathan, S.; Han, J.W.; Kwon, D.-N.; Kim, J.-H. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res. Lett. 2014, 9, 1–17. [Google Scholar] [CrossRef] [Green Version]
  20. Wang, Y.; Zhang, X.; Bai, Y.; Li, W.; Li, X.; Xing, X.; Wang, C.; Gao, L.; Yogi, M.; Swamy, M.K. Anticancer and Antibacterial Activities of Silver Nanoparticles (AgNPs) Synthesized from Cucumis melo L. J. Nanosci. Nanotechnol. 2020, 20, 4143–4151. [Google Scholar] [CrossRef]
  21. Das, G.; Patra, J.K.; Nagaraj Basavegowda, C.N.V.; Shin, H.-S. Comparative study on antidiabetic, cytotoxicity, antioxidant and antibacterial properties of biosynthesized silver nanoparticles using outer peels of two varieties of Ipomoea batatas (L.) Lam. Int. J. Nanomed. 2019, 14, 4741. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Salleh, A.; Naomi, R.; Utami, N.D.; Mohammad, A.W.; Mahmoudi, E.; Mustafa, N.; Fauzi, M.B. The potential of silver nanoparticles for antiviral and antibacterial applications: A mechanism of action. Nanomaterials 2020, 10, 1566. [Google Scholar] [CrossRef] [PubMed]
  23. Jadczak, P.; Kulpa, D.; Drozd, R.; Przewodowski, W.; Przewodowska, A. Effect of AuNPs and AgNPs on the Antioxidant System and Antioxidant Activity of Lavender (Lavandula angustifolia Mill.) from In Vitro Cultures. Molecules 2020, 25, 5511. [Google Scholar] [CrossRef] [PubMed]
  24. Vanlalveni, C.; Lallianrawna, S.; Biswas, A.; Selvaraj, M.; Changmai, B.; Rokhum, S.L. Green synthesis of silver nanoparticles using plant extracts and their antimicrobial activities: A review of recent literature. RSC Adv. 2021, 11, 2804–2837. [Google Scholar] [CrossRef]
  25. Laouini, S.E.; Bouafia, A.; Soldatov, A.V.; Algarni, H.; Tedjani, M.L.; Ali, G.A.; Barhoum, A. Green synthesized of Ag/Ag2O nanoparticles using aqueous leaves extracts of phoenix dactylifera L. And their azo dye photodegradation. Membranes 2021, 11, 468. [Google Scholar] [CrossRef]
  26. Meretoudi, A.; Banti, C.N.; Raptis, P.K.; Papachristodoulou, C.; Kourkoumelis, N.; Ikiades, A.A.; Zoumpoulakis, P.; Mavromoustakos, T.; Hadjikakou, S.K. Silver Nanoparticles from Oregano Leaves’ Extracts as Antimicrobial Components for Non-Infected Hydrogel Contact Lenses. Int. J. Mol. Sci. 2021, 22, 3539. [Google Scholar] [CrossRef]
  27. Kadhim, M.; Aldujaili, A.; Homady, M. Assessment of hepatoprotective role of phenolic extract of Urtica dioica and silver nanoparticles in male rat induced by carbon tetra-chloride. Rasayan J. Chem. 2017, 10, 305–312. [Google Scholar]
  28. Nassar, A.M. Research Article Effectiveness of Silver Nano-particles of Extracts of Urtica urens (Urticaceae) Against Root-knot Nematode Meloidogyne incognita. Asian J. Nematol. 2016, 5, 14–19. [Google Scholar] [CrossRef]
  29. Jyoti, K.; Baunthiyal, M.; Singh, A. Characterization of silver nanoparticles synthesized using Urtica dioica Linn. leaves and their synergistic effects with antibiotics. J. Radiat. Res. Appl. Sci. 2016, 9, 217–227. [Google Scholar] [CrossRef] [Green Version]
  30. Joshi, N.C.; Kumar, V.; Singh, A.; Singh, R. Characterisations, Antimicrobial activities and Biological synthesis of silver (Ag) nanoparticles using the leaf extract of Urtica dioica. Res. J. Pharm. Technol. 2019, 12, 4429–4433. [Google Scholar] [CrossRef]
  31. Flieger, J.; Franus, W.; Panek, R.; Szymańska-Chargot, M.; Flieger, W.; Flieger, M.; Kołodziej, P. Green Synthesis of Silver Nanoparticles Using Natural Extracts with Proven Antioxidant Activity. Molecules 2021, 26, 4986. [Google Scholar] [CrossRef] [PubMed]
  32. Khanam, R.; Prasuna, R.G. Comparison of extraction methods and solvents for total phenolics from dairy waste. Asian J. Dairy Food Res. 2017, 36, 251–255. [Google Scholar] [CrossRef] [Green Version]
  33. Joshi, D.R.; Adhikari, N. An overview on common organic solvents and their toxicity. J. Pharm. Res. Int. 2019, 28, 1–18. [Google Scholar] [CrossRef]
  34. Thouri, A.; Chahdoura, H.; El Arem, A.; Omri Hichri, A.; Ben Hassin, R.; Achour, L. Effect of solvents extraction on phytochemical components and biological activities of Tunisian date seeds (var. Korkobbi and Arechti). BMC Complementary Altern. Med. 2017, 17, 248. [Google Scholar] [CrossRef] [PubMed]
  35. Jadou, A.; Al-Shahwany, A.W. Biogenic Synthesis and Characterization of Silver Nanoparticles Using Some Medical Plants and Evaluation of Their Antibacterial and Toxicity Potential. J. AOAC Int. 2018, 101, 1905–1912. [Google Scholar] [CrossRef] [PubMed]
  36. Khan, M.; Tang, H.; Lyles, J.; Pineau, R.; Mashwani, Z.R.; Quave, C.L. Antibacterial properties of medicinal plants from Pakistan against multidrug-resistant ESKAPE pathogens. Front. Pharmacol. 2018, 9, 815. [Google Scholar] [CrossRef] [Green Version]
  37. Loo, Y.Y.; Rukayadi, Y.; Nor-Khaizura, M.-A.-R.; Kuan, C.H.; Chieng, B.W.; Nishibuchi, M.; Radu, S. In vitro antimicrobial activity of green synthesized silver nanoparticles against selected gram-negative foodborne pathogens. Front. Microbiol. 2018, 9, 1555. [Google Scholar] [CrossRef]
  38. Alfuraydi, A.A.; Devanesan, S.; Al-Ansari, M.; AlSalhi, M.S.; Ranjitsingh, A.J. Eco-friendly green synthesis of silver nanoparticles from the sesame oil cake and its potential anticancer and antimicrobial activities. J. Photochem. Photobiol. B Biol. 2019, 192, 83–89. [Google Scholar] [CrossRef]
  39. Shi, X.; Zou, J.; Chen, X.; Zheng, H.; Jin, Z.; Li, F.; Piao, J.-G. The Effect of Size on the Surface Enhanced Raman Scattering Property of SiO2@PDA@AgNP Core-Shell-Satellite Nanocomposite. Chem. Lett. 2020, 49, 534–537. [Google Scholar] [CrossRef]
  40. Haider, A.; Ijaz, M.; Ali, S.; Haider, J.; Imran, M.; Majeed, H.; Shahzadi, I.; Ali, M.M.; Khan, J.A.; Ikram, M. Green synthesized phytochemically (Zingiber officinale and Allium sativum) reduced nickel oxide nanoparticles confirmed bactericidal and catalytic potential. Nanoscale Res. Lett. 2020, 15, 1–11. [Google Scholar] [CrossRef]
  41. Mikhailova, E.O. Silver nanoparticles: Mechanism of action and probable bio-application. J. Funct. Biomater. 2020, 11, 84. [Google Scholar] [CrossRef] [PubMed]
  42. Rama, P.; Baldelli, A.; Vignesh, A.; Altemimi, A.B.; Lakshmanan, G.; Selvam, R.; Arunagirinathan, N.; Murugesan, K.; Pratap-Singh, A. Antimicrobial, antioxidant, and angiogenic bioactive silver nanoparticles produced using Murraya paniculata (L.) jack leaves. Nanomater. Nanotechnol. 2022, 12. [Google Scholar] [CrossRef]
  43. Devanesan, S.; Jayamala, M.; AlSalhi, M.S.; Umamaheshwari, S.; Ranjitsingh, A.J.A. Antimicrobial and Anticancer properties of Carica papaya leaves derived di-methyl flubendazole mediated silver nanoparticles. J. Infect. Public Health 2021, 14, 577–587. [Google Scholar] [CrossRef] [PubMed]
  44. Sallehudin, T.A.T.; Seman, M.N.A.; Chik, S.M.S.T. Preparation and Characterization Silver Nanoparticle Embedded Polyamide Nanofiltration (NF) Membrane. ATEC Web Conf. 2018, 150, 02003. [Google Scholar]
  45. Carvalho, P.M.; Felício, M.R.; Santos, N.C.; Gonçalves, S.; Domingues, M.M. Application of light scattering techniques to nanoparticle characterization and development. Front. Chem. 2018, 6, 237. [Google Scholar] [CrossRef]
  46. Rahdar, A.; Amini, N.; Askari, F.; Susan, M.; Hasan, A.B. Dynamic light scattering: A useful technique to characterize nanoparticles. J. Nanoanal. 2019, 6, 80–89. [Google Scholar]
  47. Wong, A.; Liu, Q.; Griffin, S.; Nicholls, A.; Regalbuto, J. Synthesis of ultrasmall, homogeneously alloyed, bimetallic nanoparticles on silica supports. Science 2017, 358, 1427–1430. [Google Scholar] [CrossRef] [Green Version]
  48. Lomelí-Rosales, D.A.; Zamudio-Ojeda, A.; Reyes-Maldonado, O.K.; López-Reyes, M.E.; Basulto-Padilla, G.C.; Lopez-Naranjo, E.J.; Zuñiga-Mayo, V.M.; Velázquez-Juárez, G. Green Synthesis of Gold and Silver Nanoparticles Using Leaf Extract of Capsicum chinense Plant. Molecules 2022, 27, 1692. [Google Scholar] [CrossRef]
  49. Jahan, S.T.; Sadat, S.; Walliser, M.; Haddadi, A. Targeted therapeutic nanoparticles: An immense promise to fight against cancer. J. Drug Deliv. 2017, 2017, 9090325. [Google Scholar] [CrossRef]
  50. Jurj, A.; Braicu, C.; Pop, L.-A.; Tomuleasa, C.; Gherman, C.D.; Berindan-Neagoe, I. The new era of nanotechnology, an alternative to change cancer treatment. Drug Des. Dev. Ther. 2017, 11, 2871. [Google Scholar] [CrossRef] [Green Version]
  51. Scimeca, M.; Bischetti, S.; Lamsira, H.K.; Bonfiglio, R.; Bonanno, E. Energy Dispersive X-ray (EDX) microanalysis: A powerful tool in biomedical research and diagnosis. Eur. J. Histochem. EJH 2018, 62, 2841. [Google Scholar] [CrossRef]
  52. Arshad, H.; Sami, M.A.; Sadaf, S.; Hassan, U. Salvadora persica mediated synthesis of silver nanoparticles and their antimicrobial efficacy. Sci. Rep. 2021, 11, 5996. [Google Scholar] [CrossRef] [PubMed]
  53. Pareek, V.; Devineau, S.; Sivasankaran, S.K.; Bhargava, A.; Panwar, J.; Srikumar, S.; Fanning, S. Silver nanoparticles induce a triclosan-like antibacterial action mechanism in multi-drug resistant Klebsiella pneumoniae. Front. Microbiol. 2021, 12, 183. [Google Scholar] [CrossRef] [PubMed]
  54. Hameed, A.S.H.; Karthikeyan, C.; Ahamed, A.P.; Thajuddin, N.; Alharbi, N.S.; Alharbi, S.A.; Ravi, G. In vitro antibacterial activity of ZnO and Nd doped ZnO nanoparticles against ESBL producing Escherichia coli and Klebsiella pneumoniae. Sci. Rep. 2016, 6, 24312. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Baptista, P.V.; McCusker, M.P.; Carvalho, A.; Ferreira, D.A.; Mohan, N.M.; Martins, M.; Fernandes, A.R. Nano-strategies to fight multidrug resistant bacteria—“A Battle of the Titans”. Front. Microbiol. 2018, 9, 1441. [Google Scholar] [CrossRef] [Green Version]
  56. Lee, J.; Monk, I.; Goncalves da Silva, A.; Seemann, T.; Chua, K.Y.L.; Kearns, A.; Hill, R.; Woodford, N.; Bartels, M.D.; Strommenger, B.; et al. Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis. Nat. Microbiol. 2018, 3, 1175–1185. [Google Scholar] [CrossRef]
  57. Brayner, R.; Ferrari-Iliou, R.; Brivois, N.; Djediat, S.; Benedetti, M.F.; Fiévet, F. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett. 2006, 6, 866–870. [Google Scholar] [CrossRef]
  58. Panpaliya, N.P.; Dahake, P.T.; Kale, Y.J.; Dadpe, M.V.; Kendre, S.B.; Siddiqi, A.G.; Maggavi, U.R. In vitro evaluation of antimicrobial property of silver nanoparticles and chlorhexidine against five different oral pathogenic bacteria. Saudi Dent. J. 2019, 31, 76–83. [Google Scholar] [CrossRef]
  59. Dizaj, S.M.; Lotfipour, F.; Barzegar-Jalali, M.; Zarrintan, M.H.; Adibkia, K. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater. Sci. Eng. C 2014, 44, 278–284. [Google Scholar] [CrossRef]
  60. Yun’an Qing, L.C.; Li, R.; Liu, G.; Zhang, Y.; Tang, X.; Wang, J.; Liu, H.; Qin, Y. Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies. Int. J. Nanomed. 2018, 13, 3311. [Google Scholar] [CrossRef] [Green Version]
  61. Yang, W.; Shen, C.; Ji, Q.; An, H.; Wang, J.; Liu, Q.; Zhang, Z. Food storage material silver nanoparticles interfere with DNA replication fidelity and bind with DNA. Nanotechnology 2009, 20, 085102. [Google Scholar] [CrossRef]
Microorganisms 10 00789 g001 550
Figure 1. Ethyl acetate extract of UD leaves mediated the preparation of AgNPs. (a) Silver nitrate solution; (b) mixture of plant extract and silver nitrate; (c) formation of AgNPs.
Figure 1. Ethyl acetate extract of UD leaves mediated the preparation of AgNPs. (a) Silver nitrate solution; (b) mixture of plant extract and silver nitrate; (c) formation of AgNPs.
Microorganisms 10 00789 g001
Microorganisms 10 00789 g002 550
Figure 2. UV–vis spectrum of the UD-AgNPs recorded at different time points.
Figure 2. UV–vis spectrum of the UD-AgNPs recorded at different time points.
Microorganisms 10 00789 g002
Microorganisms 10 00789 g003 550
Figure 3. FTIR spectrum. (a) Ethyl acetate UD leaves extract; (b) UD-AgNPs with different functional groups.
Figure 3. FTIR spectrum. (a) Ethyl acetate UD leaves extract; (b) UD-AgNPs with different functional groups.
Microorganisms 10 00789 g003
Microorganisms 10 00789 g004 550
Figure 4. XRD pattern of the UD-AgNPs with peak values.
Figure 4. XRD pattern of the UD-AgNPs with peak values.
Microorganisms 10 00789 g004
Microorganisms 10 00789 g005 550
Figure 5. DLS Zetasizer analysis (a) Size distribution of the synthesized UD-AgNPs (b) Zeta potential of the synthesized UD-AgNPs.
Figure 5. DLS Zetasizer analysis (a) Size distribution of the synthesized UD-AgNPs (b) Zeta potential of the synthesized UD-AgNPs.
Microorganisms 10 00789 g005
Microorganisms 10 00789 g006 550
Figure 6. EADX spectrum observed elemental distribution Ag–L, C–K, O–K and Cl–K from synthesized UD-AgNPs.
Figure 6. EADX spectrum observed elemental distribution Ag–L, C–K, O–K and Cl–K from synthesized UD-AgNPs.
Microorganisms 10 00789 g006
Microorganisms 10 00789 g007 550
Figure 7. (a–d) SEM with different magnifications (a) 5 µm and (b) 10 µm; TEM images with different magnifications (c) 100 nm and (d) 200 nm exhibiting the formation of UD-AgNPs.
Figure 7. (a–d) SEM with different magnifications (a) 5 µm and (b) 10 µm; TEM images with different magnifications (c) 100 nm and (d) 200 nm exhibiting the formation of UD-AgNPs.
Microorganisms 10 00789 g007
Microorganisms 10 00789 g008 550
Figure 8. ZOI (a) control groups (DMSO, UD extract, and AgNO3) and (b) synthesized UD-AgNPs against S. aureus, E. faecalis, S. epidermidis, E. coli, K. pneumoniae, and P. aeruginosa.
Figure 8. ZOI (a) control groups (DMSO, UD extract, and AgNO3) and (b) synthesized UD-AgNPs against S. aureus, E. faecalis, S. epidermidis, E. coli, K. pneumoniae, and P. aeruginosa.
Microorganisms 10 00789 g008
Microorganisms 10 00789 g009 550
Figure 9. Resazurin Plate assay showing the MIC values of the UD-AgNPs against S. aureus, E. faecalis, S. epidermidis, E. coli, K. pneumoniae, and P. aeruginosa.
Figure 9. Resazurin Plate assay showing the MIC values of the UD-AgNPs against S. aureus, E. faecalis, S. epidermidis, E. coli, K. pneumoniae, and P. aeruginosa.
Microorganisms 10 00789 g009
Table
Table 1. The zone of inhibition observed for different bacterial isolates and different amounts of UD-AgNPs.
Table 1. The zone of inhibition observed for different bacterial isolates and different amounts of UD-AgNPs.
Zone of Inhibition (mm)
Bacteria25 uL (Mean ± SD)50 uL (Mean ± SD)75 uL (Mean± SD)Control
S. aureus13.3 ± 0.716.6 ± 0.421.3 ± 0.724 ± 1
E. faecalis12.6 ± 0.414 ± 118.6 ± 0.427 ± 1
S.epidermidis14.3 ± 0.717.6 ± 0.619 ± 115.6 ± 0.6
K. pneumoniae16.3 ± 0.717.3 ± 0.719.6 ± 0.626 ± 1
P. aeruginosa16 ± 118.6 ± 0.421.6 ± 0.416 ± 1
E. coli13.6 ± 0.617 ± 119.6 ± 0.624.3 ± 0.7
Table
Table 2. Minimum inhibitory concentrations (MICs) and minimum bactericidal concentration (MBC) of UD-AgNPs against Gram-positive and Gram-negative bacteria.
Table 2. Minimum inhibitory concentrations (MICs) and minimum bactericidal concentration (MBC) of UD-AgNPs against Gram-positive and Gram-negative bacteria.
BacteriaMIC (µg/mL) (Mean ± SD)MBC (µg/mL) (Mean ± SD)
S. aureus40 ± 092 ± 17
S. epidermidis38 ± 3233 ± 33
E. faecalis42 ± 883 ± 17
K. pneumoniae40 ± 0333 ± 33
P. aeruginosa40 ± 0133.± 33
E. coli37± 375 ± 00
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Binsalah, M.; Devanesan, S.; AlSalhi, M.S.; Nooh, A.; Alghamdi, O.; Nooh, N. Biomimetic Synthesis of Silver Nanoparticles Using Ethyl Acetate Extract of Urtica diocia Leaves; Characterizations and Emerging Antimicrobial Activity. Microorganisms 2022, 10, 789. https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms10040789

AMA Style

Binsalah M, Devanesan S, AlSalhi MS, Nooh A, Alghamdi O, Nooh N. Biomimetic Synthesis of Silver Nanoparticles Using Ethyl Acetate Extract of Urtica diocia Leaves; Characterizations and Emerging Antimicrobial Activity. Microorganisms. 2022; 10(4):789. https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms10040789

Chicago/Turabian Style

Binsalah, Mohammed, Sandhanasamy Devanesan, Mohamad S. AlSalhi, Abdullrahman Nooh, Osama Alghamdi, and Nasser Nooh. 2022. "Biomimetic Synthesis of Silver Nanoparticles Using Ethyl Acetate Extract of Urtica diocia Leaves; Characterizations and Emerging Antimicrobial Activity" Microorganisms 10, no. 4: 789. https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms10040789

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop